Cite
HARVARD Citation
Hill, D. et al. (n.d.). P1‐155: The path to regulatory qualification of low baseline hippocampal volume as a prognostic biomarker in clinical trials of patients with early Alzheimer's disease: For the coalition against major diseases. Alzheimer's & dementia. p. P404. [Online].